Alternative initiations of three-monthly and six-monthly paliperidone palmitate in a psychiatric hospitalization unit. About two clinical cases.

被引：0
|
作者：
Calvo, V. Juarez [1 ]
Villarino, C. Rodriguez [1 ]
Garcia, M. Presa [1 ]
机构：
[1] Hosp Cent Def Gomez Ulla, Ctr Sanitario Vida & Esperanza, Serv Psiquiatria & Salud Mental, Madrid, Spain
来源：
EUROPEAN PSYCHIATRY | 2023年 / 66卷
关键词：
D O I：
10.1192/j.eurpsy.2023.2318
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPV1025
引用
收藏
页码：S1091 / S1091
页数：1
相关论文
共 6 条
  • [1] Discontinuation and relapse with paliperidone palmitate three-monthly for maintenance of schizophrenia: Two year follow-up of use in clinical practice
    Wallman, Phoebe
    Clark, Ivana
    Taylor, David
    JOURNAL OF PSYCHOPHARMACOLOGY, 2021, 35 (09) : 1091 - 1098
  • [2] Factors Associated with Symptom Stabilization that Allow for Successful Transition from Once-Monthly Paliperidone Palmitate to Three-Monthly Paliperidone Palmitate: A Post Hoc Analysis Examined Clinical Characteristics in Chinese Patients with Schizophrenia
    Xin Li
    Chong Ye
    Wanyi Zhang
    Miaomiao Jia
    Gang Wang
    CNS Drugs, 2024, 38 : 55 - 65
  • [3] Factors Associated with Symptom Stabilization that Allow for Successful Transition from Once-Monthly Paliperidone Palmitate to Three-Monthly Paliperidone Palmitate: A Post Hoc Analysis Examined Clinical Characteristics in Chinese Patients with Schizophrenia
    Li, Xin
    Ye, Chong
    Zhang, Wanyi
    Jia, Miaomiao
    Wang, Gang
    CNS DRUGS, 2024, 38 (01) : 55 - 65
  • [4] Initiation of three-monthly palmitate paliperidone long-acting formulation in French clinical practice: results from the OPTIMUS study
    Gary, C.
    Deal, C.
    Boursicot-Beuzelin, J.
    Guilton, P.
    Falissard, B.
    Giordana, J. Y.
    Fakra, E.
    Samalin, L.
    Bouju, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S456 - S457
  • [5] Evaluation of three-monthly palmitate paliperidone long-acting formulation use in clinical practice based on the French healthcare claim database
    Gary, C.
    Deal, C.
    Boursicot-Beuzelin, J.
    Bouee, S.
    Tessier, C.
    Falissard, B.
    Giordana, J. Y.
    Fakra, E.
    Samalin, L.
    Bouju, S.
    Guillon, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S261 - S262
  • [6] The clinical and economic impact of three-monthly long-acting formulation of paliperidone palmitate versus the one-monthly formulation in the treatment of schizophrenia in France: A cost-utility study
    Duarte, C. H. Arteaga
    Fakra, E.
    Van Gils, C.
    Guillon, P.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2019, 45 (06): : 459 - 467
1